Paper444352
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
Curry SH and 4 others. Br J Clin Pharmacol, 1979. Cited by 67 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man. Papers, record 444352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/444352
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluphenazine | Major topic |
| Adult | |
| Chlorides | |
| Chromatography, Gas | |
| Chromatography, Thin Layer | |
| Decanoates | |
| Half-Life | |
| Heptanoates | |
| Humans | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,191,384 | ESTERS OF 4-(3-(2-(TRIFLUOROMETHYL)PHENOTHIAZIN-10-YL)PROPYL)-1-PIPERAZINEUETHANOL AS LONG-ACTING TRANQUILIZING AGENTS. SYNTHESIS OF 4-(3-(2-(TRIFLUOROMETHYL)-PHENOTHIAZIN-10-YL)PROPYL)-1-PIPERAZINEUETHANOL-ETHYL-C14 AND ITS ESTER WITH HEPTANOIC ACID. 3. | J Med Chem | 1963 | https://conductscience.org/library/papers/14191384 | PubMed |
| 2 | 12,260 | Methods for study of fluphenazine kinetics in man. | J Pharm Pharmacol | 1976 | https://conductscience.org/library/papers/12260 | PubMed |
| 3 | 566,109 | Radioimmunoassay for fluphenazine in human plasma. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/566109 | PubMed |
| 4 | 5,081,368 | Pharmacokinetic studies on flupenthixol and flupenthixol decanoate in man using tritium labelled compounds. | Psychopharmacologia | 1972 | https://conductscience.org/library/papers/5081368 | PubMed |
| 5 | 4,115,602 | Double-blind trial of fluphenazine decanoate. | Lancet | 1972 | https://conductscience.org/library/papers/4115602 | PubMed |
| 6 | 4,771,900 | [Metabolic studies with long-acting compounds]. | Therapie | 1973 | https://conductscience.org/library/papers/4771900 | PubMed |
| 7 | 4,749,993 | Determination of perphenazine and fluphenazine in whole blood by gas chromatography. | Med Lab Technol | 1973 | https://conductscience.org/library/papers/4749993 | PubMed |
| 8 | 4,711,886 | Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine. | Dis Nerv Syst | 1973 | https://conductscience.org/library/papers/4711886 | PubMed |
| 9 | 4,710,310 | The problem of clinical activity of long-acting neuroleptics. | Compr Psychiatry | 1973 | https://conductscience.org/library/papers/4710310 | PubMed |
| 10 | 948,990 | Determination of fluphenazine in plasma by ion-pair partition chromatography. | Acta Pharm Suec | 1976 | https://conductscience.org/library/papers/948990 | PubMed |
| 11 | 5,128,931 | Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog. | J Pharm Sci | 1971 | https://conductscience.org/library/papers/5128931 | PubMed |
| 12 | 5,560,899 | Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. | Br J Pharmacol | 1971 | https://conductscience.org/library/papers/5560899 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,044,597 | Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/36044597 | PubMed |
| 25,360,245 | The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. | Ther Adv Psychopharmacol | 2014 | https://conductscience.org/library/papers/25360245 | PubMed |
| 22,261,306 | Improving the prediction of the brain disposition for orally administered drugs using BDDCS. | Adv Drug Deliv Rev | 2012 | https://conductscience.org/library/papers/22261306 | PubMed |
| 9,279,892 | Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil. | Pharm Res | 1997 | https://conductscience.org/library/papers/9279892 | PubMed |
| 7,900,948 | Pharmacokinetic optimisation of the treatment of psychosis. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/7900948 | PubMed |
| 7,439,258 | Pharmacokinetic studies in volunteers of intravenous and oral cis (Z)-flupentixol and intramuscular cis (Z)-flupentixol decanoate in Viscoleo. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7439258 | PubMed |
| 7,306,433 | Radioimmunoassay for trifluoperazine in human plasma. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7306433 | PubMed |
| 6,812,119 | Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6812119 | PubMed |
| 6,787,637 | Fluphenazine pharmacokinetics and therapeutic response. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6787637 | PubMed |
| 6,777,812 | Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6777812 | PubMed |
| 6,771,823 | Comparative enzyme-inducing effects of chlorpromazine and fluphenazine therapies in psychotic patients. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6771823 | PubMed |
| 6,662,169 | Kinetics of oral fluphenazine disposition in humans by GC-MS. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6662169 | PubMed |
| 6,146,995 | Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6146995 | PubMed |
| 6,140,703 | Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment. | Psychopharmacology (Berl) | 1983 | https://conductscience.org/library/papers/6140703 | PubMed |
| 3,933,037 | Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia. | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/3933037 | PubMed |
| 3,933,035 | Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients. | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/3933035 | PubMed |
| 3,148,147 | Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/3148147 | PubMed |
| 3,128,820 | Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/3128820 | PubMed |
| 3,127,851 | Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/3127851 | PubMed |
| 3,124,166 | The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/3124166 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/444352
GET https://conductscience.org/api/papers/v1/444352/cited_by?page=2